vida: extract claims from 2025-07-01-cell-med-glp1-societal-implications-equity
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run

- Source: inbox/queue/2025-07-01-cell-med-glp1-societal-implications-equity.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
This commit is contained in:
Teleo Agents 2026-04-26 04:16:08 +00:00
parent 6ccd1ac1af
commit 090deff895
2 changed files with 11 additions and 1 deletions

View file

@ -23,3 +23,10 @@ Despite the near-doubling of year-one persistence rates, Prime Therapeutics data
**Source:** KFF 2025 poll
Cost is a major driver of discontinuation: 14% of former GLP-1 users stopped due to cost, matching the 13% who stopped due to side effects. Among current users, 56% report difficulty affording medications, suggesting cost pressure operates throughout the treatment duration, not just at initiation. The 27% of insured users paying full out-of-pocket cost indicates insurance coverage gaps contribute to persistence failures.
## Extending Evidence
**Source:** Cell/Med 2025, The Societal Implications of Using GLP-1 Receptor Agonists for the Treatment of Obesity
Cell/Med 2025 connects low persistence rates to the sustainability concern: chronic use model + high prices + discontinuation effects = fiscal unsustainability at scale. The paper notes need to 'consider acceptability over long term and implications for weight stigma,' suggesting that persistence barriers are not just clinical or financial but also social. The equity inversion compounds this: those with highest need face both highest discontinuation rates (per existing KB claims on wealth-stratified access) and lowest initial access, creating a double barrier to population-level impact.

View file

@ -7,9 +7,12 @@ date: 2025-07-01
domain: health
secondary_domains: []
format: commentary-analysis
status: unprocessed
status: processed
processed_by: vida
processed_date: 2026-04-26
priority: high
tags: [glp-1, obesity, equity, health-disparities, access, social-determinants, prevention, societal-implications]
extraction_model: "anthropic/claude-sonnet-4.5"
---
## Content